Martin Michels
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Cancer Mechanisms and Therapy, Porphyrin and Phthalocyanine Chemistry, Chronic Lymphocytic Leukemia Research, Synthesis and Biological Evaluation
Most-Cited Works
- → BAY 87‐2243, a highly potent and selective inhibitor of hypoxia‐induced gene activation has antitumor activities by inhibition of mitochondrial complex I(2013)223 cited
- → Quinazolinone Derivatives as Orally Available Ghrelin Receptor Antagonists for the Treatment of Diabetes and Obesity(2007)157 cited
- → “Figure Eight” Cyclooctapyrroles: Enantiomeric Separation and Determination of the Absolute Configuration of a Binuclear Metal Complex(1999)134 cited
- → Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity(2016)117 cited
- → Discovery and SAR of Novel 2,3‐Dihydroimidazo[1,2‐c]quinazoline PI3K Inhibitors: Identification of Copanlisib (BAY 80‐6946)(2016)113 cited
- → Spirodiporphyrins—As Binuclear Metal Complexes(2003)95 cited
- → Encapsulation and Stabilization of Reactive Aromatic Diazonium Ions and the Tropylium Ion Within a Supramolecular Host(2004)62 cited
- → Hydrophobic Chemistry in Aqueous Solution: Stabilization and Stereoselective Encapsulation of Phosphonium Guests in a Supramolecular Host(2004)62 cited
- → BAY 1125976, a selective allosteric AKT1/2 inhibitor, exhibits high efficacy on AKT signaling‐dependent tumor growth in mouse models(2016)59 cited
- → BAY 1143269, a novel MNK1 inhibitor, targets oncogenic protein expression and shows potent anti-tumor activity(2017)57 cited